The Role of Promising Therapeutic Target, Plasminogen-binding Protein (PbsP), in the Pathogenicity of S. agalactiae and Development of Neonatal GBS Meningitis
Megan Branum Background: Neonatal invasive GBS disease is the leading cause of infection-related neonatal morbidity and mortality globally, caused by the bacterium Streptococcus agalactiae, colloquially known as Group-B Streptococcus (GBS).1-4 After transmission from asymptomatically colonized genitourinary tracts of pregnant women, GBS utilizes virulence factors for pathogenic invasion of neonates.1-4 Current…